News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
733,484 Results
Type
Article (60949)
Company Profile (106)
Press Release (672409)
Multimedia
Podcasts (141)
Webinars (23)
Section
Business (191737)
Career Advice (2993)
Deals (35631)
Drug Delivery (146)
Drug Development (82562)
Employer Resources (171)
FDA (16244)
Job Trends (15194)
News (335228)
Policy (33210)
Tag
2027 BioCapital Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Standard (1)
2027 Genetown Standard (2)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (4)
Academia (2814)
Academic (2)
Accelerated approval (46)
Adcomms (34)
Allergies (181)
Alliances (47051)
ALS (210)
Alzheimer's disease (1837)
Antibody-drug conjugate (ADC) (443)
Approvals (16576)
Artificial intelligence (685)
Autoimmune disease (275)
Automation (54)
Bankruptcy (336)
Best Places to Work (11878)
BIOSECURE Act (21)
Biosimilars (218)
Biotechnology (71)
Bladder cancer (188)
Brain cancer (76)
Breast cancer (748)
Cancer (5803)
Cardiovascular disease (477)
Career advice (2562)
Career pathing (47)
CAR-T (336)
CDC (65)
Celiac Disease (3)
Cell therapy (910)
Cervical cancer (47)
Clinical research (71279)
Collaboration (2081)
Company closure (7)
Compensation (1116)
Complete response letters (93)
COVID-19 (2836)
CRISPR (111)
C-suite (1144)
Cystic fibrosis (158)
Data (7678)
Decentralized trials (3)
Denatured (51)
Depression (167)
Dermatology (76)
Diabetes (583)
Diagnostics (7106)
Digital health (52)
Diversity (13)
Diversity, equity & inclusion (45)
Drug discovery (334)
Drug pricing (221)
Drug shortages (31)
Duchenne muscular dystrophy (270)
Earnings (77288)
Editorial (75)
Employer branding (20)
Employer resources (153)
Events (117696)
Executive appointments (1130)
FDA (19960)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (35)
Funding (1718)
Gene editing (240)
Generative AI (62)
Gene therapy (718)
GLP-1 (1095)
Government (5208)
Grass and pollen (8)
Guidances (407)
Healthcare (19925)
HIV (80)
Huntington's disease (52)
IgA nephropathy (91)
Immunology and inflammation (286)
Immuno-oncology (91)
Indications (173)
Infectious disease (3182)
Inflammatory bowel disease (217)
Inflation Reduction Act (15)
Influenza (140)
Intellectual property (292)
Interviews (568)
IPO (16847)
IRA (54)
Job creations (3653)
Job search strategy (2108)
JPM (65)
Kidney cancer (20)
Labor market (88)
Layoffs (624)
Leadership (47)
Legal (7807)
Liver cancer (97)
Longevity (34)
Lung cancer (764)
Lymphoma (422)
Machine learning (61)
Management (60)
Manufacturing (994)
MASH (187)
Medical device (14337)
Medtech (14436)
Mergers & acquisitions (20070)
Metabolic disorders (1510)
mRNA (217)
Multiple sclerosis (188)
NASH (16)
Neurodegenerative disease (421)
Neuropsychiatric disorders (112)
Neuroscience (3361)
Neurotech (1)
NextGen: Class of 2026 (6862)
Non-profit (4836)
Now hiring (34)
Obesity (716)
Opinion (332)
Ovarian cancer (210)
Pain (258)
Pancreatic cancer (300)
Parkinson's disease (363)
Partnered (34)
Patents (597)
Patient recruitment (670)
Peanut (65)
People (62782)
Pharmaceutical (28)
Pharmacy benefit managers (32)
Phase 1 (22198)
Phase 2 (31349)
Phase 3 (23249)
Pipeline (8025)
Policy (348)
Postmarket research (2737)
Preclinical (9672)
Press Release (63)
Prostate cancer (298)
Psychedelics (56)
Radiopharmaceuticals (337)
Rare diseases (1070)
Real estate (6232)
Recruiting (70)
Regulatory (25645)
Reports (47)
Research institute (2541)
Resumes & cover letters (461)
Rett syndrome (37)
RNA editing (22)
RSV (89)
Schizophrenia (181)
Series A (290)
Series B (205)
Service/supplier (8)
Sickle cell disease (112)
Special edition (25)
Spinal muscular atrophy (172)
Sponsored (50)
Startups (3484)
State (1)
Stomach cancer (16)
Supply chain (124)
Tariffs (86)
The Weekly (87)
Vaccines (1155)
Venture capital (109)
Weight loss (465)
Women's health (116)
Worklife (23)
Date
Last 7 days (786)
Last 30 days (2748)
Last 365 days (30837)
2026 (10855)
2025 (30990)
2024 (35343)
2023 (40132)
2022 (51211)
2021 (56255)
2020 (55090)
2019 (48563)
2018 (36835)
2017 (33210)
2016 (32648)
2015 (38302)
2014 (31013)
2013 (26782)
2012 (28353)
2011 (28825)
2010 (27288)
Location
Africa (963)
Alabama (96)
Alaska (7)
Arizona (305)
Arkansas (16)
Asia (42516)
Australia (7522)
California (12676)
Canada (3689)
China (1336)
Colorado (539)
Connecticut (559)
Delaware (394)
Europe (99343)
Florida (1921)
Georgia (431)
Hawaii (3)
Idaho (66)
Illinois (1072)
India (89)
Indiana (601)
Iowa (21)
Japan (520)
Kansas (131)
Kentucky (51)
Louisiana (42)
Maine (79)
Maryland (1560)
Massachusetts (8991)
Michigan (377)
Minnesota (718)
Mississippi (7)
Missouri (156)
Montana (36)
Nebraska (26)
Nevada (140)
New Hampshire (91)
New Jersey (3455)
New Mexico (32)
New York (3390)
North Carolina (1676)
North Dakota (9)
Northern California (6304)
Ohio (388)
Oklahoma (26)
Oregon (43)
Pennsylvania (2515)
Puerto Rico (27)
Rhode Island (45)
South America (1344)
South Carolina (85)
South Dakota (2)
Southern California (5034)
Tennessee (207)
Texas (2050)
United States (45356)
Utah (380)
Vermont (1)
Virginia (322)
Washington D.C. (75)
Washington State (1035)
West Virginia (4)
Wisconsin (137)
Wyoming (2)
733,484 Results for "public relations society of america prsa".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Intellia Announces Proposed Public Offering of Common Stock
April 28, 2026
·
5 min read
Press Releases
Veradermics Announces Launch of Public Offering
April 28, 2026
·
5 min read
Press Releases
Avalyn Announces Pricing of Upsized Initial Public Offering
April 29, 2026
·
4 min read
Press Releases
Intellia Therapeutics Announces Pricing of Public Offering of Common Stock - April 29, 2026
April 29, 2026
·
5 min read
Press Releases
Hemab Therapeutics Announces Pricing of Upsized Initial Public Offering
May 1, 2026
·
4 min read
Press Releases
Seaport Therapeutics Announces Pricing of Upsized Initial Public Offering
May 1, 2026
·
4 min read
Press Releases
Altimmune Announces Proposed Underwritten Public Offering of Securities
April 23, 2026
·
4 min read
Press Releases
Veradermics Announces Pricing of Upsized Public Offering and Private Placement
April 30, 2026
·
5 min read
Press Releases
Kailera Therapeutics Announces Pricing of Initial Public Offering
April 17, 2026
·
2 min read
Regulatory
FDA asks 2,200 drug developers to make trial results public, ramping up transparency push
Some 30% of clinical trials that are mandated to report their findings have not posted results to clinicaltrials.gov, the federal government’s public repository for studies, according to internal data from the FDA.
April 14, 2026
·
2 min read
·
Tristan Manalac
1 of 73,349
Next
